Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04662879 · ClinicalTrials.gov registry record · NA
Early Detection Initiative for Pancreatic Cancer
A NA study of Diabetes Mellitus and Hyperglycemia, sponsored by Pancreatic Cancer Action Network.
- Active
- Registry status
- NA
- Development phase
- 8,869
- Enrollment target
- 2
- Study locations
NCT04662879: Active NA study of Diabetes Mellitus and Hyperglycemia, sponsored by Pancreatic Cancer Action Network.
NCT04662879 is a NA study of Diabetes Mellitus and Hyperglycemia that is active but no longer recruiting, run by Pancreatic Cancer Action Network. The registered enrollment target is 8,869 participants, above the 1,825-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (386% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04662879, a NA study of Diabetes Mellitus and Hyperglycemia, is active but no longer recruiting, sponsored by Pancreatic Cancer Action Network.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 8,869 participants
- Enrollment target
- 2
- Study locations
Study Summary
The Early Detection Initiative for Pancreatic Cancer is a multi-center prospective study to determine if algorithm-based screening in patients with glycemically defined new onset hyperglycemia and diabetes has the potential for earlier detection of pancreatic ductal adenocarcinoma.
Primary Outcome
Prospectively validate the ENDPAC model.
Conditions Studied
Interventions
- OTHER Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC) score
- OTHER Abdominal imaging
Study Locations (2)
California
- Kaiser Permanente Southern California, Kaiser Permanente Research - Pasadena
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,869 participants |
| Start Date | 2021-10-14 |
| Est. Completion | 2028-01 |
| Phase | NA |
What the registry record for NCT04662879 still lists
NCT04662879 is an interventional study that assigns participants to a tested intervention. Its 8,869 participants enrollment target places it among the larger protocols in the corpus, above the 1,825-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (386% higher).
The record links to 3 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC) score is the first listed.
NCT04662879 reports a single indexed study location in California, Texas.
Frequently Asked Questions
What is clinical trial NCT04662879 about?
NCT04662879 is a clinical study titled "Early Detection Initiative for Pancreatic Cancer". The Early Detection Initiative for Pancreatic Cancer is a multi-center prospective study to determine if algorithm-based screening in patients with glycemically defined new onset hyperglycemia and diabetes has the potential for earlier detection of pancreatic ductal adenocarcinoma.
What is the current status of trial NCT04662879?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 8,869 participants. The study started on 2021-10-14. Estimated completion is 2028-01.
What conditions does trial NCT04662879 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Hyperglycemia, Pancreas Ductal Adenocarcinoma.
What interventions are being tested in trial NCT04662879?
The interventions under investigation include: Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC) score (OTHER), Abdominal imaging (OTHER).
Who is sponsoring clinical trial NCT04662879?
This trial is sponsored by Pancreatic Cancer Action Network, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04662879 being conducted?
This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04662879's enrollment target sits among peer trials
8,869 9th of 208 higher than 200 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05612347 · 8,946 participants · NA
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- NCT05336877 · 8,744 participants
Aveir VR Coverage With Evidence Development Post-Approval Study
- NCT02000089 · 9,000 participants · Phase 3
The Cancer of the Pancreas Screening-5 CAPS5)Study
- NCT06058234 · 8,680 participants
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI